newsfilter
← Latest News
GlobeNewswire·

Opiant Receives FDA Fast Track Designation for OPNT003, Nasal Nalmefene, for Treatment of Opioid Overdose

Fast Track Designation further underscores the potential for OPNT003 to represent a major advance in the treatment of opioid overdose as opioid overdose deaths surge1 This designation enables early and frequent communication with the FDA, in addition